Back to Search
GURKAMAL CHATTA, MD
MD
Medical Oncology Physician
NPI: 1114999083IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD00025531(WA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD228838(OR)284329(NY)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1981
Research & Publications (20)
Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
PMID 19213668·Clin Genitourin Cancer·2009
3-trial
A double-blind randomized crossover study of oral thalidomide versus placebo for androgen dependent prostate cancer treated with intermittent androgen ablation.
PMID 19167733·J Urol·2009
2-rct
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study.
PMID 19396016·Anticancer Drugs·2009
3-trial
Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.
PMID 18710748·J Urol·2008
3-trial
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies.
PMID 18519777·Clin Cancer Res·2008
3-trial
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel.
PMID 17960793·Cancer·2008
4-observational
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
PMID 17437819·J Urol·2007
3-trial
Phase I and pharmacodynamic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with refractory advanced cancers.
PMID 17363531·Clin Cancer Res·2007
3-trial
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
PMID 17308271·J Clin Oncol·2007
4-observational
The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial.
PMID 18272025·Clin Genitourin Cancer·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- ELM AND CARLTON ST
BUFFALO, NY 14263 - Phone
- (716) 845-2300
Quick Facts
- NPI
- 1114999083
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile